A Phase 2 Randomized Double-blind Placebo-controlled Evaluation of the Safety and Efficacy of BMS-986165 with Background Treatment in Subjects with Lupus Nephritis

Brief description of study

The purpose of this research study is to see if a test medicine named BMS-986165 will help treat kidney inflammation caused by lupus nephritis. It will also test how safe it is to use the medicine in people. This test medicine is considered investigational, meaning the US Food and Drug Administration (FDA) has not approved it for sale to patients.

Clinical Study Identifier: s18-01414
ClinicalTrials.gov Identifier: NCT03943147
Principal Investigator: Amit Saxena.
Other Investigator: Janine M. Sullivan.

If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.